Next-Generation eCOA/ePRO Provider uMotif Welcomes SAFIRA Clinical Research Co-founder and Clinical Trial Technology Innovator Willie Muehlhausen as Scientific Advisor


Wilhelm Muehlhausen, SAFIRA Clinical Research Co-founder

‘We’re delighted to welcome Willie Muehllhausen as a Scientific Advisor. He has a remarkable track record of advancing technologies that make clinical trials run faster and smoother for sponsors, CROs, sites and patients.’ -uMotif CEO Steve Rosenberg

uMotif – one of the clinical trial technology market’s fastest growing companies – reiterated its status as the pacesetter in next-generation eCOA/ePRO by welcoming SAFIRA Clinical Research Co-founder and international eClinical technology expert Willie Muehlhausen as a Scientific Advisor.

uMotif’s highly scalable eCOA/ePRO platform combines deep clinical knowledge and consumer design expertise to deliver unprecedented levels of patient compliance, regularly achieving greater than 90% data capture in real-world studies. Over 20+ years, Willie Muehlhausen has earned a reputation as a strategic thinker, serial entrepreneur and visionary in patient-facing clinical research technologies at organizations in Germany, the UK, Ireland and the US. He is known for his ability to ideate and develop groundbreaking new product lines and commercial models.

uMotif CEO Steve Rosenberg (LinkedIn) said, “We’re delighted to welcome Willie Muehllhausen to uMotif as a Scientific Advisor. He has a remarkable track record of advancing technologies that make clinical trials run faster and smoother for sponsors, CROs, sites and patients. And he’s earned a stellar reputation as an independent arbiter of emerging eClinical technologies.”

As early as 2004, Muehlhausen’s insights into patient-centric questionnaire validation had a positive impact on the way regulators and the industry approached eCOA, which paved the way for the BYOD (Bring Your Own Device) research model. He co-founded SAFIRA Clinical Research in 2021 to offer services to decentralized clinical trial technology vendors, sponsors and CROs. SAFIRA Clinical Research has become the go-to organization for providing unbiased, independent, scientific technology and product evaluations.

Prior to SAFIRA Clinical Research, Muehlhausen was Founder and Managing Director of Muehlhausen Ltd, where he advised sponsors, vendors, investment companies and researchers on digitization strategies for remote and virtual clinical trials. He conducted pioneering research on direct-to-patient models including BYOD, eCOA and wearables.

Also previously, Muehlhausen was with ICON plc for several years, most recently as VP and Head of Innovation. His achievements included the ICONIK toolset for proactively managing clinical trials; ICON’s eCOA solution; ICHOM GLOBE, a leading initiative in healthcare and outcomes research; and wearable devices.

Willie Muehlhausen commented, “I have always been impressed by uMotif’s insights and expertise, and their ability to consistently take important steps forward in delivering next-generation eCOA/ePRO solutions that make quantifiable improvements in research, by truly engaging patients. For example, late last year SAFIRA Clinical Research independently and scientifically validated the Motif data capture method as the first alternative to text-based instruments for clinical, post-marketing and real-world research. It gives researchers a new way to encourage patients to capture data, through a more visually appealing interface.”

At ISPOR 2023, May 8 in Boston, Muehlhausen will present a poster, “The First Validated Innovation in Scale Design Since the Migration to Screens: Results of an Equivalence Study, Testing a New Graphical Version of the Widely Used Verbal Rating Scale,” based on SAFIRA’s evaluation of the Motif.

Muehlhausen has served as Vice Director of the eCOA Consortium/Critical Path Institute (C-Path). His industry recognition includes being named one of the PharmaVOICE 100 most influential people in life sciences, and winning a CenterWatch Top 20 Innovator award.

About uMotif

Putting patients first is in uMotif’s DNA. The uMotif eCOA/ePRO platform delivers faster, quality clinical trials and real-world studies by putting patients at the core of research. Through cloud hosting in the US, Europe and China, the GCP, 21 CFR Part 11 and GDPR-compliant platform supports any study or trial, from Clinical Phase I, II and III studies through to decentralized or virtual real-world studies. Find out how uMotif can improve your clinical research programs and real-world studies at http://www.umotif.com

Share article on social media or email:

Allergy Standards CSO Dr. John Ryan to Speak at ISSA Pulire 2023, Addressing the Importance of Indoor Air Quality and ESG Needs


“Through the iAIR Academy and our partnership with GBAC, we aim to raise awareness of the importance of indoor air quality and to equip professionals with the knowledge and tools to make a positive difference,” said Dr. John Ryan, CSO of ASL and GBAC Ambassador.

Allergy Standards Ltd (ASL), the international standards and certification body, announced today that Dr. John Ryan, the company’s Chief Strategy Officer, will speak at ISSA Pulire 2023 with a talk entitled ‘Cleaning For Purpose Not Just Appearance.’

The talk will address how the professional cleaning and sanitising industry can make a significant positive impact on indoor air quality and align their services with the ESG needs of their customers.

As the global population spends up to 90% of their time indoors, the importance of indoor air quality has never been more crucial. The cleaning and sanitising industry plays a pivotal role in maintaining a healthy indoor environment, and Dr. Ryan’s talk will explore how this industry can adopt an approach that focuses on cleaning for purpose, not just appearance.The talk will highlight how the cleaning and sanitising industry can positively impact the indoor environment by reducing allergens, pollutants and pathogens that can cause respiratory and other health issues. Dr. Ryan will provide insights on how the industry can better align its services with the ESG needs of their customers, helping companies become more sustainable and socially responsible.

Allergy Standards has partnered with GBAC, a division of ISSA, to offer the ‘Healthier Buildings Awareness’ Course through the indoor Air Innovation and Research (iAIR) Academy (iAIR Academy). The iAIR Academy provides comprehensive training solutions to help enterprises achieve a healthy and safe indoor environment. The ‘Healthier Buildings Awareness’ course provides participants with the knowledge and tools to better understand the relationship between indoor air quality and human health, and to adopt best practices in building management and cleaning to create healthier indoor environments.

Additionally, following on from the recent announcement of ASL’s collaboration with the Indoor Air Quality Society, ASL will further expand their presence in the EU market by announcing the European launch of the “Verified as Healthier Air” mark. The “Verified as Healthier Air” label validates the air quality of indoor environments or products, passing rigorous review for cleaner and fresh air. With this label, occupants and consumers can have confidence in cleaner air, promoting healthier living and working environments.

“Indoor air quality is a growing concern for people around the world, and the cleaning and sanitising industry can make a significant positive impact by adopting a cleaning for purpose approach. Through the iAIR Academy and our partnership with GBAC, we aim to raise awareness of the importance of indoor air quality and to equip professionals with the knowledge and tools to make a positive difference,” said Dr. John Ryan, CSO of ASL and GBAC Ambassador.

ISSA Pulire Milan is the most important Italian trade fair entirely dedicated to professional cleaning and is an unmissable opportunity for those in the sector to discover the latest trends and innovations, network, and upskill. The event includes seminars, workshops, and presentations on key themes such as sustainability, green cleaning, digitalization, and workplace safety.

Dr. John Ryan’s talk, ‘Cleaning For Purpose Not Just Appearance,’ will take place at ISSA Pulire 2023, which is scheduled for May 9-11th, 2023, in Milan, Italy.

About ASL

Our mantra is design thinking and innovation for the air aware consumer. As an independent, international certification company, we create peer-reviewed, scientific standards for a wide range of products and services to determine their impact on indoor air quality. ASL’s intellectual property portfolio includes unique protocols for products to be CERTIFIED asthma & allergy friendly®. Our mission is to make the United Nations human right to breathe clean air a reality, through science (Standards), education (Academy) and innovation (Institute). http://www.allergystandards.com/

About the iAIR Academy

The indoor Air Innovation and Research (iAIR) Academy provides comprehensive training solutions to help enterprises achieve a healthy and safe indoor environment. The academy specializes in providing training programs that cover various aspects of indoor air quality, from identifying common pollutants to implementing effective ventilation and air filtration strategies, emphasizing practical solutions that are backed by scientific research and industry best practices. https://www.iair.academy

Share article on social media or email:

uMotif and Veramed Partner to Offer Advanced Biostatistical Data Analysis, Visualization Combined with Industry-Leading Patient eCOA/ePRO Data Capture and Analytics


News Image

“By working with Veramed, we can offer customers significant increases in the benefit they get from collecting and analyzing huge volumes of solid eCOA/ePRO data, for any therapeutic area, geography, or patient population.” -uMotif CEO Steve Rosenberg

uMotif – one of the clinical trial technology market’s fastest growing companies – continues to redefine how eCOA/ePRO data is collected, reported, visualized and analyzed with the announcement of a strategic partnership with advanced biostatistics consultancy Veramed.

The highly-scalable uMotif eCOA/ePRO platform combines the industry’s most innovative eCOA/ePRO technology with an unmatched focus on true patient centricity. The modern platform consistently achieves greater than 90 percent compliance, generating double the expected volume of data in real-world studies.

Veramed brings people, innovation, and technology together to accelerate evidence generation and advance patient health, with end-to-end biometrics and engaging data visualizations that help organize large amounts of data and speed decision making for key stakeholders. Veramed’s in-house analysis and visualization platform seamlessly pulls together and compares data collected in clinical trials for a number of different treatments, performing network meta-analysis with the click of a few buttons.

Together, uMotif and Veramed generate high quality, actionable insights to drive quantifiable improvements in clinical research. Through the partnership with Veramed, sponsors get the unique advantages of the industry’s most advanced data analysis and visualization support on top of uMotif’s market-leading platform for ePRO/eCOA data capture, reporting, and analytics.

During ISPOR 2023, May 7-10 in Boston, uMotif (Booth #923) and Veramed (Booth #1225) will demonstrate an example of their combined capabilities with a must-see data visualization of the large-scale “100 for Parkinson’s” study which engaged more than 4,200 participants to capture ePRO, symptom, device and motor-testing data over 100 days.

Matt Jones, Veramed Co-founder and CEO, commented, “Working with a partner like uMotif enables us to help customers understand and act on massive volumes of quality eCOA/ePRO data in ways that were not possible before.”

uMotif CEO Steve Rosenberg (LinkedIn) said, “By working with Veramed, we can offer customers significant increases in the benefit they get from collecting and analyzing huge volumes of solid eCOA/ePRO data, for any therapeutic area, geography, or patient population.”

About Veramed

Veramed is a people-focused clinical research organization and certified B Corp that provides its clients with the assurance and close collaboration across mid-stream, analysis and reporting, as well as post-reporting and submission stages of the clinical trial process. Headquartered in London, we serve clients around the world from offices in the UK, US, EU, and Ukraine. http://www.veramed.co.uk

About uMotif

Putting patients first is in uMotif’s DNA. The uMotif eCOA/ePRO platform delivers faster, quality clinical trials and real-world studies by putting patients at the core of research. Through cloud hosting in the US, Europe and China, the GCP, 21 CFR Part 11 and GDPR-compliant platform supports any study or trial, from Clinical Phase I, II and III studies through to decentralized or virtual real-world studies. Find out how uMotif can improve your clinical research programs and real-world studies at http://www.umotif.com

Share article on social media or email:

22 Salute™ CEO Eric Ranks Opens Up About Health Struggles in the Growth of his Company


Eric Ranks recently shared details about his own health issues while in the early stages of creating his award winning vodka, 22 Salute Vodka ‘With A Purpose’™. Eric was diagnosed with leukemia before age 6 and struggled with depression. He was suicidal and after his divorce, nearly ended his life with an accidental overdose of antidepressants.

Eric was initially drawn to the topic of veteran health after managing a team of employees that had served overseas. He watched in anger as the VA refused to cover injuries caused by Agent Orange to a friend. Eric had been raised in a military family and in 2012, he left corporate America and started his non profit, The Veteran’s Connection™. Its initial mission was to help speed up the process to help veterans receive their benefits.

In 2015, Eric suffered internal bleeding and was rushed to the ER for life saving blood transfusions. He was diagnosed with an autoimmune disease and with the help of a ketogenic diet, was able to stabilize his condition. The next few years would again challenge Eric’s spirit as he faced a ruptured esophagus and survived a life threatening surgery.

Eric dedicated his efforts to suicide prevention and veteran support with his non profit and his 22 Salute Spirits and Coffee ‘With A Purpose’™. Eric’s mission was forged by his many health scares and it gave him a vision of what his life should be: dedication to helping others in need. Where most people would find struggle with health issues, it gave Eric purpose.

“I have been through many challenges, including health scares, an accidental overdose and a surgery that nearly cost me my life. I want to encourage all veterans and first responders to keep fighting. I believe in you.” – Eric Ranks, CEO of 22 Salute Spirits and Coffee™

Find out more at http://www.22salute.com

#spirits, #vodka, #beverage, #cocktails, #health

Share article on social media or email:

Protect Environmental and the American Lung Association Announce National Partnership to Prevent Radon-Induced Lung Cancer


Exposure to radon at 4.0 picocuries equals 200 chest X-rays per year or 8 cigarettes per day.  EPA recommends fixing your home

Know your number – learn how radon could impact your health

“Radon in homes is more common than you think. In fact, every state in the U.S. has homes measured with radon levels above the recommended levels,” Deb Brown, chief mission officer for the American Lung Association said.

Protect Environmental, in conjunction with the American Lung Association, announced today the national partnership between the two organizations to prevent radon-induced lung cancer. The announcement comes during the kickoff of Lung Cancer Action Week, an initiative focused on raising awareness and building support for improved lung health. Exposure to radon is the leading cause of lung cancer among non-smokers, second only to smoking, and is responsible for more than 21,000 annual deaths in the United States.

“Radon in homes is more common than you think. In fact, every state in the U.S. has homes measured with radon levels above the recommended levels. Since it is odorless, tasteless, and colorless, all indoor spaces should be tested regardless of geographic location and building type,” said Deb Brown, chief mission officer for the American Lung Association. “This is why we are thankful for our partnership with Protect Environmental to help raise awareness about radon and provide testing for more people. Together we hope to reduce the burden of lung cancer caused by radon.”

As part of the national partnership, Protect Environmental will provide its National Radon Risk Search™ tool and offer no-cost professional testing to assist American Lung Association supporters with understanding the radon risk in their communities and homes. The organizations will also partner to amplify national, state, and local policy initiatives that impact lung health, with Protect Environmental pledging more than $100,000 to support these joint efforts.

“The American Lung Association has been a long-time friend of Protect Environmental, and we are excited to be expanding our relationship through this strategic partnership,” said Kyle Hoylman, chief executive officer of Protect Environmental and a member of the American Lung Association’s Local Leadership Board in Kentucky. “Joining forces with the leading lung health advocate in our country will amplify our efforts to increase awareness about the dangers of radon gas exposure, with the ultimate goal of saving lives by preventing radon-induced lung cancer.”

To learn more about the radon risk in your community, use the National Radon Risk Search ™ tool. To better understand the radon risk in your own home, request no-cost professional testing conducted by one of Protect Environmental’s trusted professionals. Learn more about the partnership with the Lung Association at Lung.org/Protect-Environmental.

About Protect Environmental

Protect Environmental is a national leader in the environmental consulting and construction industry, focusing on radon and chemical vapor intrusion management. With a proven track record spanning 18 years and more than 200,000 completed projects in all 50 U.S. states and 2 U.S. territories, the company provides expert service from its trusted professionals to provide peace of mind protection to property owners seeking to build and maintain healthy, safe, and sustainable indoor environments. Join our rapidly expanding team, https://apply today. For more information, call 502-410-5000 or click on https://www.protectenvironmental.com.

About the American Lung Association

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, a holder of the coveted 4-star rating from Charity Navigator and a Platinum-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit:Lung.org.

Share article on social media or email:

You Do Not Have to Make a Choice Between God and Science


News Image

This book shows that science and faith aren’t in mutual opposition, but highly complementary.

Author James A. Cannon, Ph.D. explains the faith behind physics in Finding the Light: Science and its Vision ($15.99, paperback, 9781662865787; $29.99, dust jacket, 9781662865794; $7.99, e-book, 9781662865800).

Contrary to the popular belief that science opposes Christian faith, Cannon teaches that historical physical science, as well as modern physics, follow faith’s universal promptings within the human heart. He demonstrates how both have flourished together in the lives of prominent scientists throughout history, and argues that faith in God is a guardian of classical realism, the philosophical foundation of science.

This book shows that science and faith aren’t in mutual opposition, but highly complementary.

Dr. James A Cannon (b.1933 – d.2020), after serving in the US Navy during the Korean war, studied and practiced journalism as managing editor of the Fordham University newspaper. Then he switched his area of concentration to physics. He earned an MA at Columbia and a B.S. and Ph.D. at Fordham. He did basic research at Bell Labs, but having the heart of a teacher, he left to pursue a career spanning five decades as a revered professor of physics and chemistry at Pace University in New York. A neurological injury led to retirement. He suffered for a dozen years until complications from Parkinson’s and Covid-19 took his life. During this time, with of the able assistance of his devoted wife, Monica, Dr. Cannon wrote Finding the Light: Science and its Vision, a testament to his life’s work, his Catholic faith, his love of science and his love of teaching.

Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 15,000 titles published to date.Finding the Light is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.

Share article on social media or email:

Sadler Sports & Recreation Insurance Announces Release of 2023 Youth Football Insurance Program


News Image

Complete your entire insurance transaction and receive documents in as little as 10 minutes.

Sadler Sports & Recreation Insurance has announced its 2023 insurance and risk management program for football teams, associations and conferences. The program is endorsed by American Youth Football and American Youth Cheer.

11,000+ youth tackle/flag/cheer teams experience an incredible combination of savings, speed and ease of enrollment with our instant online quote/pay/print, broad coverages, easy to implement risk management templates for the protection of players and volunteers, and personalized service when you need it.

Sadler’s youth football/cheer insurance program has consistently set the bar in the industry with its custom coverages, low rates, automated enrollment including instant issuance of documents/certificates, and free best in industry risk management resources. This includes a Sample AYF/AYC Risk Management Plan, Brain Injury/Concussion Risk Management Plan for Youth Tackle Football / Cheer, and Safe Sport Child Abuse Plan.

Unlike most competitors, the Sadler/AYF program automatically includes critical General Liability coverage for Sex Abuse & Molestation and Non Owned and Hired Auto Liability.

The automated system allows clients to apply for coverage online and complete the entire transaction from application to receipt of documents in as little as 10 minutes. Clients have the ability to print their documents and access other services at any time through the user-friendly website, http://www.sadlersports.com/ayf.

Their highly-rated customer service agents can be contacted via phone, online chat, and email.

Sadler Sports & Recreation continuously looks to educate coaches, players, administrators and parents on injury prevention, and is a leader in bringing awareness to the issues surrounding child abuse and brain injury. The AYF/AYC Risk Management Plan is a template that can be adopted and implemented by administrators and serves as written documentation of procedures and educational awareness training. The template is a single source for policies and procedures on child abuse prevention, brain injury, sudden cardiac arrest, heat illness, lightning safety, emergency action plan, instruction, supervision, facilities, equipment, sports injury care, and auto safety. Sadler was the industry leader in 2020 with its COVID return to play risk management templates which allowed many leagues to continue with their seasons (where allowed by state and local law) while reducing risk of COVID transmission liability.

Sadler also automatically includes purchasers of the AYF/AYC-endorsed program in a database from which injury data is gathered to produce injury reports. Information from these reports have been part of important studies comparing injuries among age groups only vs injuries in age/weight categories and concussions within AYF/AYC.

Check out the list of impressive AYF/AYC membership benefits.

Find out more about our program here: https://www.youtube.com/watch?v=NV3T5HUf0bY

Share article on social media or email:

Recovery Unplugged Treatment Centers Launches New Program for Co-Occurring Trauma and Substance Use Disorder


Trauma Healing

Trauma Healing

Key themes include boundaries and communication; grief, trauma, and loss; and shame and vulnerability.

Recovery Unplugged Treatment Centers is pleased and excited to announce a new program for the millions of Americans struggling with trauma and addiction.

Developed in accordance with the organization’s philosophy of treating the whole individual and helping them build a fulfilling life in recovery, the program provides comprehensive treatment for the medical and lifestyle impact of substance abuse while also addressing the related trauma through a personalized course of behavioral therapy.

The Recovery Unplugged trauma track is offered through our residential treatment program in Austin, TX. Care includes group therapy and individualized counseling from Master’s-level clinicians; 24-hour medical provider access for medication management; supplemental therapies such as meditation, cognitive-behavioral therapy, and mindfulness exercises; and personalized case management services. The program also offers access to Recovery Unplugged’s robust and extensive alumni community and events.

Key themes include boundaries and communication; grief, trauma, and loss; and shame and vulnerability. Treatment lasts an average of three weeks and is covered by most major insurances. The program launched on May 1st and is open to individuals throughout the country.

In a time when post-traumatic stress disorder (PTSD) affects over six percent of the American population and over 46 million Americans struggle with substance use disorder, addressing the overlap between these two conditions has never been more urgent. “Frequently individuals who come to treatment for addiction don’t realize that trauma has been a significant factor driving their use, says Joseph Gorordo, LCDC, Senior Vice-President, Austin Operations and Outreach. “Our goal is to help them identify the relationship between their trauma and substance abuse in order to heal both and give them the best opportunity possible at changing their lives.”

For more information about the Recovery Unplugged Trauma program, visit RecoveryUnplugged.com.

About Recovery Unplugged

Recovery Unplugged is a licensed and accredited treatment provider that uses a music-assisted approach to help clients heal from substance use disorder. Combining traditional elements of care, such as medical detoxification, behavioral rehab, and medication-assisted treatment, with innovative music-focused practices, Recovery Unplugged is the only addiction care provider to fully integrate music into every aspect of our treatment model.

With locations in Fort Lauderdale and Lake Worth, FL; Austin, TX, Brentwood, TN; Annandale, VA; and Merchantville, NJ, Recovery Unplugged offers all levels of treatment, including inpatient, outpatient, and online rehab options. Recovery Unplugged is accredited by the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) and is in-network with most major insurance providers.

Share article on social media or email:

Mount Sinai Health System Celebrates Its 38th Annual Crystal Party in Person After Four Years


“We celebrate what philanthropy makes possible: Mount Sinai’s ability to provide the highest-quality health care, educate the next generation of great clinicians and researchers, and generate scientific breakthroughs that advance the capabilities of modern medicine” – Dean Dennis S. Charney, MD

Mount Sinai Health System celebrated its 38th annual Crystal Party on Thursday, May 4, returning to an in-person event at the Central Park Conservatory Garden after four years.

The event raised $3 million and there were 800 guests including Mount Sinai leadership, staff, patients, supporters, and more. This year’s benefit chairs were Dina Powell McCormick and David McCormick.

“We celebrate what philanthropy makes possible: Mount Sinai’s ability to provide the highest-quality health care, educate the next generation of great clinicians and researchers, and generate scientific breakthroughs that advance the capabilities of modern medicine. That is exactly what we have been doing since we last gathered here,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System.

During the event, an inspiring video was shown highlighting three special patients and the care they received at Mount Sinai. They included a Ukrainian teen who fled the war in her country to come to New York and receive a life-saving heart procedure at Mount Sinai with the help of her sister and two Mount Sinai pediatric cardiologists, Barry Love, MD, and Robert Pass, MD. Additionally, a Staten Island child with multiple health problems—visual impairment, Crohn’s disease, and a rare bone disease—received life-affirming care from the team of doctors and Child Life team at Mount Sinai Kravis Children’s Hospital, including David Dunkin, MD, Rebecca Trachtman, MD, and Cemre Robinson, MD. Lastly, a renowned television chef whose lungs were damaged by exposure at the World Trade Center after 9/11 received Mount Sinai’s first double lung transplant, with the help of Raja Flores, MD, and Scott Scheinin, MD. These patient stories showcase just a few examples of how Mount Sinai physicians and staff continue go above and beyond in finding a way to provide the best possible care to patients.

“Mount Sinai’s outstanding work in the past few years in our hospitals, our clinics, our classrooms, and labs has furnished our reputation as one of the truly great academic medical centers, not only in this country, but in the world. This is all about the people we have, so my tribute is to all of the doctors, the faculty, the researchers, all of those at Mount Sinai. Thank you for making this place as great as it is,” said Richard A. Freidman, Co-Chair, the Board of Trustees, Mount Sinai Health System.

The funds raised will help support a variety of programs and departments across the Mount Sinai Health System. Please find the video here along with a link to images and with names of guests from Mount Sinai’s 38th Annual Crystal Party included. Photo credit: Mount Sinai Health System.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

RAM Technologies, Inc., Leading BPaaS Provider for Government Sponsored Healthcare, Ranked by Philadelphia Business Journal as Top Technology Employer


Owning and operating on our own platform is a tremendous differentiator and keeps RAM well positioned to quickly address new and evolving regulatory changes that are so common in our space.

RAM Technologies, Inc. (RAM), the leading technology enabled services provider to Medicare Advantage and Managed Medicaid health plans, today announced they have been named to the Philadelphia Business Journal’s list of leading businesses in the region – Top Technology Employers. This is the 15th consecutive year RAM has received this honor in recognition of their continued growth and outstanding service to the government sponsored health plan market.

Ranked by the volume of employees in the Greater Philadelphia region, this Pennsylvania-based organization continued their exponential growth, adding highly experienced staff to RAM’s already impressive BPaaS division to accommodate the addition of eight (8) new clients onboarded since April of 2021, and RAM continues their aggressive recruiting to meet increasing demand for outsourcing and digital transformation in the government sponsored health plan workplace.

“This selection reaffirms our position in the market and our commitment to delivering quality services and outcomes for our government sponsored healthcare clients. Being recognized by the Philadelphia Business Journal is an accolade we do not take lightly,” stated Christopher P. Minton, Executive Vice President of RAM Technologies, Inc. “We are proud of our growth and the consistency we have established, and look forward to continuing to deliver tangible value to health plans operating in the Medicare Advantage and Managed Medicaid markets.”

Mr. Minton added, “The value RAM delivers to our clients is derived from highly experienced industry leaders and operators who have built a highly automated and innovative shared service model. We leverage our own end-to-end technology platform (HEALTHsuite Advantage™) to meet the business and regulatory requirements for our clients. Owning and operating on our own platform is a tremendous differentiator and keeps RAM well positioned to quickly address new and evolving regulatory changes that are so common in our space.”

The Philadelphia Business Journal’s list of Top Technology Employers represents the most influential software developers, system integrators and computer consultants throughout the region.

RAM’s solutions, HEALTHsuite Advantage enterprise core and eHealthsuite™ web portals, coupled with the services offering from RAM Health Services (RAM’s onshore internal BPaaS division), represent the next evolution in healthcare administration. HEALTHsuite Advantage deploys in a pre-configured state ready to administer ‘Original’ Medicare. This innovative approach slashes implementation durations, eliminates risk and greatly reduces costs. HEALTHsuite Advantage’s robust features and functions include all of the essential core system capabilities, including complete bi-directional integration with CMS – a must for Medicare Advantage and Managed Medicaid organizations.

About RAM:

RAM Technologies is the leading provider of enterprise claims processing software and CMS Integration tools for health care organizations administering Medicare Advantage, Special Needs and Managed Medicaid plans. For over 40 years RAM Technologies has led the way in the creation of benefit administration software for these programs and continues to enhance their managed care software to meet the needs of a rapidly changing market. RAM Technologies has been recognized on Inc. Magazine’s List of Fastest Growing Private Companies and the Philadelphia Business Journal’s List of Top Software Developers for their advancements in the creation of comprehensive auto adjudication software for Medicare and SNP administration. To learn more about RAM Technologies’ healthcare claims processing solutions call (877) 654-8810 or visit http://www.ramtechinc.com.

Share article on social media or email: